Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) is a publicly traded Healthcare sector company. As of July 29, 2026, ARCT trades at $5.89 with a market cap of $163.72M and a P/E ratio of -2.02. ARCT moved +0.00% today. Year to date, ARCT is -6.20%; over the trailing twelve months it is -60.01%. Its 52-week range spans $5.50 to $24.17. Analyst consensus is buy with an average price target of $20.00. Rallies surfaces ARCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ARCT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $5.89 |
| Market Cap | $163.72M |
| P/E Ratio | -2.02 |
| EPS | $-2.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.17 |
| 52-Week Low | $5.50 |
| Volume | 311.90K |
| Avg Volume | 0 |
| Revenue (TTM) | $54.71M |
| Net Income | $-78.67M |
| Gross Margin | 0.00% |
7 analysts cover ARCT: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.00.